Agrawal M, Surendran AK, Biswas R. Letter Re: Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial. Eur J Cancer 2025 Apr 23:115442. doi: 10.1016/j.ejca.2025.115442.
PMID: 40287356